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Abstract
Background: Efforts to prevent the development of overweight and obesity have increasingly focused early in the
life course as we recognise that both metabolic and behavioural patterns are often established within the first few
years of life. Randomised controlled trials (RCTs) of interventions are even more powerful when, with forethought,
they are synthesised into an individual patient data (IPD) prospective meta-analysis (PMA). An IPD PMA is a unique
research design where several trials are identified for inclusion in an analysis before any of the individual trial
results become known and the data are provided for each randomised patient. This methodology minimises the
publication and selection bias often associated with a retrospective meta-analysis by allowing hypotheses, analysis
methods and selection criteria to be specified a priori.
Methods/Design: The Early Prevention of Obesity in CHildren (EPOCH) Collaboration was formed in 2009. The
main objective of the EPOCH Collaboration is to determine if early intervention for childhood obesity impacts on
body mass index (BMI) z scores at age 18-24 months. Additional research questions will focus on whether early
intervention has an impact on children’s dietary quality, TV viewing time, duration of breastfeeding and parenting
styles. This protocol includes the hypotheses, inclusion criteria and outcome measures to be used in the IPD PMA.
The sample size of the combined dataset at final outcome assessment (approximately 1800 infants) will allow
greater precision when exploring differences in the effect of early intervention with respect to pre-specified
participant- and intervention-level characteristics.
Discussion: Finalisation of the data collection procedures and analysis plans will be complete by the end of 2010.
Data collection and analysis will occur during 2011-2012 and results should be available by 2013.
Trial registration number: ACTRN12610000789066
Background
Primary prevention of childhood overweight is an inter-
national priority [1]. In Australia in 2007, 18-21% of 2-8
year olds were already overweight, including 4-6% who
were obese [2]. Corresponding figures for New Zealand
children aged 2-14 years show 21% overweight, includ-
ing 8% who were obese [3]. Childhood overweight has
an immediate negative impact on physical and psycholo-
gical health and well-being [4,5]. In addition, overweight
children have a substantially increased risk of becoming
overweight adults, with an attendant increased risk of
morbidity and mortality [6,7].
Childhood obesity prevention studies to date have
largely targeted older children in school or community
settings, and have had limited effectiveness, partly due to
design and methodological issues [8-10]. The 2005
Cochrane Review of interventions for preventing child-
hood obesity included 22 quality trials, only three of
which included children less than five years of age [10].
A more recent systematic review of the effect of interven-
tions on weight status of children aged from birth to five
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less than two years of age [9]. However, only two of these
seven studies provided growth data and hence the major-
ity of studies in preschool aged children provide impact
evaluation rather than outcome evaluation of the direct
effect of interventions on weight status. Given that so few
studies have focused on very young children, it is likely
that existing interventions have started after feeding, eat-
ing, sleeping, television (TV) viewing and activity patterns
have been established and are more difficult to modify.
There are numerous reasons why starting interven-
tions to prevent childhood obesity very early may be
effective. Rapid early weight gain before two years of age
is associated with increased risk of overweight in later
childhood [11-13] and most excess weight gained before
puberty is gained by the age of five years (91% girls, 70%
boys) [14]. A range of potentially modifiable factors
operating early in life are also likely to be linked with
later obesity or obesity-promoting behaviours. These are
summarised below.
Dietary patterns and eating habits
A meta-analysis has shown that children who were
breastfed have significantly lower levels of obesity than
those who were formula fed [15] although this associa-
tion remains controversial [16]. The types and texture of
f o o d so f f e r e dt oi n f a n t sa st h e yt r a n s i t i o nf r o mm i l kt o
family foods are key determinants of early food prefer-
ences, intake patterns and dietary quality [17-19] which
then track to older ages and are associated with later
obesity risk [20].
Parental early feeding practices
Parental feeding practices strongly influence children’s
eating behaviours, which are firmly established by five
years of age and lay the foundation of adult eating
habits [21,22]. Parental feeding practices determine
infant exposure to food (type, amount, frequency), and
include responses (e.g. coercion) to infant feeding beha-
viour (e.g. food refusal). The degree of parental control
in child feeding (including restriction, monitoring or
pressure) is associated with later child feeding behaviour
(preferences and intake) and weight status [23].
Physical activity
Most studies show an inverse relationship between phy-
sical activity levels and adiposity in children. High levels
of physical activity reduce the likelihood of weight gain
over time [24,25]. A systematic review of strategies to
reduce obesity in children has shown that changes in
weight occur most frequently in interventions that also
demonstrate change in physical activity levels [26]. How-
ever, the systematic review noted that only 3% of studies
(n = 5) were conducted in preschool settings.
TV viewing practices and sedentary behaviours
Children who watch TV for more than two hours per
day are more likely to be obese, have unhealthy dietary
patterns and low levels of physical activity [27]. Many
young children exceed this viewing threshold and such
patterns of sedentary behaviour track throughout child-
hood [2,28].
Sleep patterns
Numerous cross-sectional and prospective studies have
linked shorter sleep duration with obesity [29-31] and
increased cardiovascular risk [32]. Studies are urgently
required to determine the effects of altering sleep pat-
terns on body weight during childhood.
Parenting style
Emerging evidence has linked parenting style (e.g.
authoritative, authoritarian, libertarian) to early feeding
practices, child eating behaviour and weight status. A
recent review concluded that the majority of the evi-
dence is cross-sectional, with only seven of 67 studies
providing longitudinal follow-up, and none including
children aged less than five years [23]. Only two studies
(both in preschools) examined whether parenting feed-
ing practices can be modified and most studies failed to
evaluate covariates, particularly maternal weight status
and family socioeconomic status.
Other potential effect modifiers
A range of other factors also influence the development
of excess weight gain in childhood and may, in turn,
modify responses to obesity prevention interventions.
These include birth weight (both low and high birth
weight) [33]; lower socioeconomic status [34]; parental,
and especially maternal, body mass index (BMI) [35];
and maternal smoking during pregnancy [35].
Overall, there is a strong argument for interventions
that start early in childhood to be effective in preventing
childhood obesity. However, there are as yet no pub-
lished trials that provide quality evidence to guide the
design, content and implementation of effective inter-
ventions that target infants. There are currently four
randomised controlled trials underway in Australia and
New Zealand (Healthy Beginnings [36], Nourish [37],
The Melbourne InFANT Program [38] and POI.NZ
[39]) that are investigating the effects of early interven-
tion in preventing childhood obesity. The trials are simi-
lar with respect to design, participants, intervention,
comparators and outcome measures. Table 1 gives the
details of each trial.
The Early Prevention of Obesity in CHildren
(EPOCH) collaboration was formed in 2009 with the
objective of conducting an IPD PMA of these trials to
provide the necessary evidence regarding the efficacy of
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in infancy. The key feature of this prospective collabora-
tion is to define and clearly specify the objectives,
research questions, specific aims, hypotheses, subject
eligibility criteria, subgroups, predictors, outcomes (pri-
mary and secondary) and the general analysis plans of
eligible studies in advance of knowing or publishing
individual trial results [40]. IPD PMA provides more
reliable estimates of treatment effects through prospec-
tively planned combined analyses of randomised con-
trolled trials.
While the individual trials in the EPOCH Collabora-
tion will provide important data in their own right,
combining such data via an IPD PMA will yield even
more powerful information. This is particularly impor-
tant in this area as any one trial, even with many hun-
dreds of children, may alone not have sufficient
statistical power to detect an overall reduction in popu-
lation-relevant outcomes. For example, to show a reduc-
tion in the prevalence of overweight/obesity at age two
years from 20% to 15%, 1800 participants would be
required. At the current recruitment and retention rates,
t h ec o m b i n e dd a t af r o mt h ef o u rE P O C Ht r i a l sw i l l
yield a final sample size of 1810 children by age two
years. The additional power conferred by the PMA,
combined with the availability of the IPD, will enable a
range of subgroup analyses to be performed, which will
explore other factors that may be associated with obesity
in children and may modify intervention effects. The
information obtained from the EPOCH Collaboration
will be used to guide decision making regarding invest-
ment in child health interventions which are effective in
reducing the prevalence of childhood obesity and asso-
ciated negative short- and long-term health outcomes.
Methods/Design
Objectives
The main questions that will be addressed by the
EPOCH Collaboration are:
1. Do early intervention programs designed to pre-
vent childhood obesity, compared with usual care,
offer clinically important benefits in terms of lower
BMI z scores at age 18-24 months; higher prevalence
Table 1 Characteristics of studies included in EPOCH Collaboration
Trial name Healthy Beginnings
33 (RCT) Nourish
34 (RCT) The Melbourne InFANT
Program
35 (cluster RCT)
POI NZ
36 (2×2 Factorial RCT)
Registration
number
ACTRN12607000168459 ACTRN12608000056392 ISRCTN81847050 NCT00892983
Funding
source
NHMRC NHMRC NHMRC HRC New Zealand
Number
randomised
N = 667 first time mothers N = 698 first time mothers N = 559 first time mothers N = 400 first time mothers
Baseline
data
Antenatal Infant aged 4-6 months Infant aged 3 months Antenatal
Primary
outcome
Child weight and height at 24
months
Child weight and height at 24
months
Child weight and height at 18
months
Child weight and height at 24
months
Usual care Wk1 child health nurse home
visit Self access to child health
clinics
Self directed access to child
health clinics
Access to 10 scheduled child
health clinic visits
First 4 wks midwife home visits;
Well Child (Plunkett) nurse: 8
visits in 5 yrs
Intervention
mode
Home visits; 8 visits over 2
years (antenatal, 1, 3, 5, 9, 12,
18, 24 months); maternal
advice
Two education peer support
modules (6 fortnightly sessions
each) commencing when infant
4-7 months and again at 13-16
months at community health
venues
Six 2 hour sessions delivered at
3 monthly intervals within pre-
existing mothers groups,
commencing at 3 months (3, 6,
9, 12, 15 and 18 months)
3 groups: sleep (home visits at 3
wks, 4 months); healthy eating
and activity (mix of 7 home
visits and group based sessions
at 1 wk + 3, 4, 7, 9, 12, 18
months) or both
Intervention
content (in
addition to
usual care)
Sustaining breastfeeding;
Timely solid food introduction;
Responsive to child cues of
hunger & satiety; Healthy child
food intake; Reduced TV
viewing; Promote active play;
The “how” of child feeding (e.
g. managing food fussiness)
Neutral repeated exposure to a
variety of foods; Responsive to
child cues of hunger & satiety;
Healthy child food intake;
Reduced TV viewing; Promote
authoritative parenting style; The
“how” of child feeding (e.g.
managing food fussiness)
Responsive to child cues of
hunger & satiety; Healthy child
food intake; Reduced TV
viewing; Promote active play;
The “how” of child feeding (e.g.
managing food fussiness)
Sustaining breastfeeding; Timely
solid food introduction;
Responsive to child cues of
hunger & satiety; Healthy child
food intake; Reduced TV
viewing; Promote active play;
The “how” of child feeding (e.g.
managing food fussiness);
Developing good sleep habits
Control
group
Usual care plus written home
safety/tobacco prevention
information at f/up sessions
plus three mail outs
Usual care plus quarterly
newsletter on general child
health messages excluding
sleep, food and activity
Usual care plus quarterly
newsletter on general child
health messages excluding
sleep, food and activity
Usual care
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child TV viewing time and higher prevalence of par-
enting styles and feeding practices that are consis-
tent with effective self regulation and development
of healthy weight status?
2. Do the effects of early interventions to prevent
childhood obesity differ according to the risk profile
of the infants and their families in terms of birth
weight, maternal education, maternal BMI and
maternal smoking status?
3. Do the intervention effects differ according to a)
mode of delivery (home, clinic or community-based),
b) intensity (number/frequency of sessions),
c) whether the intervention commenced antenatally
or after birth, and d) the extent of ‘well-child’ early
childhood services already offered in the community?
Search methods for identification of studies
Efforts to identify ongoing trials within Australia and
New Zealand that were eligible for participation in this
PMA included searches for published protocols on
online databases such as MEDLINE, EMBASE and clini-
cal trial registries, as well as internet searches for media
articles, non-peer reviewed articles and other publica-
tions using Google. Further efforts included informing
networks of the proposed PMA and approaching pre-
senters at relevant conferences and meetings. Four ran-
domised controlled trials (RCTs) were identified for
inclusion according to the criteria specified below and
the EPOCH Collaboration was formed in 2009. The
EPOCH Collaboration comprises the investigators of the
four RCTs assessing childhood obesity prevention inter-
ventions in Australasian settings and a coordination/
methodology team. These trials are the first internation-
ally to address this issue and the only trials in Australa-
sia assessing obesity prevention interventions in early
infancy. The four participating trials are all funded sepa-
rately by the Australian National Health and Medical
Research Council (NHMRC) or the New Zealand Health
Research Council. Details of the four RCTs are given in
Table 1.
Eligibility criteria for included RCTs
Eligibility criteria for trial design
To be eligible for inclusion in this IPD PMA, each trial
had to be randomised with an adequate level of alloca-
tion concealment, as outlined in the Cochrane Hand-
book for Systematic Reviews of Interventions [41]. A
minimum planned follow-up of infants to 18 months of
age was required within each trial, and the trial had to
be conducted within Australia or New Zealand. All par-
ticipating trials had to be be registered on a publicly
accessible clinical trial registry. To be considered for
inclusion in the PMA, the participating investigators had
to be blinded to their trial’s outcome data by interven-
tion group at the time the PMA objectives, research
questions, specific aims, hypotheses, subject eligibility
criteria, subgroups, predictors, outcomes (primary and
secondary) and general analysis plans were agreed upon.
Eligibility criteria for the patient population
The patient population for this PMA is restricted to first
time mothers and their healthy term babies. Mothers
and babies must be recruited into the trials prior to the
child being aged six months.
Eligibility criteria for each intervention and comparator
The intervention in each participating trial had to be a
parent-focused intervention for early childhood obesity
prevention. Early interventions were to commence
before the child was seven months old and be delivered,
at least in part, face-to-face but could be delivered in
either home, clinic or community settings.
Power calculations, sample size and expected treatment
effects
An expected final combined sample size of approxi-
mately 1800 infants will be available for this PMA. This
sample size will have 80% power at the two-sided 5%
level of significance to detect the following treatment
effects:
1 .R e d u c t i o ni nm e a nB M Izs c o r e s( S D )f r o m0 . 5 3
(0.93) (control group) to 0.41 (treatment group) [42]
2. Reduction in the prevalence of overweight/obese
children from 20% (control) to 15% (treatment) [3]
3. Increase in the prevalence of breastfeeding at
6 months from 33% (control) to 39.5% (treatment)
4. Reduction in child TV viewing time from 58 min/
day (SD 66) (control) to 49 min/day (treatment) [43]
Main Outcomes
Infant height/length and weight will be collected, BMI
calculated (weight/height
2) and BMI z score determined
in accordance with World Health Organization (WHO)
growth standards [44]. The primary outcome measure
will be BMI z score at age 18-24 months.
Secondary outcomes include:
￿ overweight/obesity prevalence
￿ breastfeeding duration
￿ child dietary quality
￿ child TV viewing time
￿ parenting styles/feeding practices
￿ sleeping patterns
￿ measures of physical activity
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Continuous outcomes will be analysed using linear mod-
els and binary outcomes will be analysed using appro-
priate generalised linear models with adjustments for
baseline values where applicable. Models will be selected
which accommodate the non-independence of observa-
tions within trials and treatment clusters and adjust for
these with a modelling framework (e.g. mixed effects
models for continuous data and generalised estimating
equations for binary data with an exchangeable correla-
tion structure). Any time to event endpoints will be ana-
lysed using appropriate models which accommodate
censored data (e.g. proportional hazards models). As a
sensitivity analysis, additional analyses will be performed
on the main outcomes which adjust for important base-
line factors.
Subgroup analyses
Subgroup analyses of both participant-level and inter-
vention-level characteristics will be performed on the
primary outcome to assess if the intervention effect dif-
fers between certain groups of children/mothers. Partici-
pant-level characteristics to be assessed include birth
weight, mother’s educational attainment, mother’sB M I
and smoking during pregnancy. Intervention-level fac-
tors which may modify the treatment effect include:
where the intervention is delivered (home, clinic or
community); intensity/frequency of sessions; timing of
intervention onset; and the presence/absence of “well-
child” services already offered in the community. Any
differences between treatment effects within subgroups
will be assessed by examining the significance of the
subgroup by intervention interaction term within the
model.
Analysis will include all randomised infants with avail-
able data and be based on intention-to-treat. Missing
data will be described and reasons for missing data
explored. The impact of missing data on conclusions
about the treatment effect on the primary outcome will
be explored where possible (e.g. using sensitivity ana-
lyses or imputation techniques).
The primary analysis will be conducted at the 0.05
level of significance. Secondary analyses also conducted
at the 0.05 level of significance will be used to supple-
ment conclusions based on the primary analysis and will
be interpreted appropriately within that context, consid-
ering the totality of evidence available. Subgroup ana-
lyses have been limited to a set of biologically plausible
and clinically meaningful set of subgroups which will be
performed on the primary endpoint only in order to
limit the potential for type I error inflation. A detailed
statistical analysis plan will be prepared and agreed
upon by the EPOCH Collaboration members prior to
final analyses.
Project management and data collection
The EPOCH Collaboration will undertake this IPD PMA
according to the methods recommended by the
Cochrane Collaboration Prospective Meta-Analysis
Methods Group [40].
Project management
Membership of the EPOCH Collaboration includes
representatives from each of the trials contributing data
to the project with an accompanying project coordina-
tion and data management structure including experts
in the fields of IPD PMA meta-analysis, data monitoring
and statistics. The project coordination team will be
responsible for all communications including organising
regular teleconferences, an annual face-to-face meeting
and newsletter updates. The data management team will
be responsible for establishing processes leading to a
commonly defined, core dataset of key variables being
available from each participant in each trial and the ana-
lysis of the subsequent data.
Data collection
The de-identified data to be collected from each of the par-
ticipating trials will correspond to the minimum data
required to answer the research questions. The specific for-
mat and coding required for the data will be developed and
agreed upon by the EPOCH Collaborators prospectively,
before the results of any trial are known. IPD for each ran-
domised participant will then be provided by each trial.
The data management team will receive and store the data
in a secure, centralised, customised database at the
NHMRC Clinical Trials Centre, University of Sydney. The
data will be checked with respect to range, internal consis-
tency, consistency with published reports and missing
items. Trial details such as randomisation methods, and
frequency and timing of the interventions will be cross-
checked against any published reports, trial protocols and
data collection sheets. Integrity of the randomisation pro-
cess will be examined by reviewing the chronological ran-
domisation sequence and pattern of assignment, as well as
the balance of prognostic factors across treatment groups
(taking into account stratification factors). Inconsistencies
or missing data will be discussed with the individual trial
data managers and any problems resolved by consensus.
Each trial will be analysed individually and the resulting
analyses and trial data will be verified by trialists before
inclusion in the EPOCH Collaboration database. New vari-
ables will be created from the common core dataset, as
required, in order to answer the research questions pro-
spectively agreed by the EPOCH Collaborators.
Ethical considerations
Data ownership and confidentiality
Participants in the individual trials have previously con-
sented to participation in their respective trial. The data
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Investigators of the included trials and ethical approval
for each of the trials has been given by their respective
Human Research Ethics Committees. The trialists
remain the custodians of their own data and retain the
right to withdraw their data from the analysis at any
time. Data will be de-identified before being shared with
the EPOCH Collaboration data management team.
Publication policy
Each trial has the right to publish the main results of
their project prior to the EPOCH Collaboration results
being published. When publishing individual results,
participating trials will aim to include reference to the
EPOCH Collaboration within the publication. Before
publication of any EPOCH manuscripts, drafts will be
circulated for comment, revision and approval by a
nominated representative of each of the participating
trials. Publications using these data will be authored on
behalf of the EPOCH Collaboration, either with specific
named authors, or on behalf of the Collaboration as a
whole and names of other participating Collaborators
will be listed in the Acknowledgements.
Data monitoring procedures
Each participating trial will have its own method of mon-
itoring data and safety. This may be in the form of a Data
and Safety Monitoring Committee (DSMC) or in some
cases an independent biostatistician. The Chief Investiga-
tors of each trial will seek to ensure that the Chairperson
of their own DSMC/biostatistician knows of the existence
of the other participating trials so that communication
can occur between them if required. The EPOCH Colla-
boration will give consideration to any requests from
DSMC Chairpersons for sharing of de-identified data
(either aggregate or IPD) should the need arise. There
are ‘in principle’ plans to update the PMA data at regular
intervals if individual trials are funded for a longer term
and follow-up data become available.
Funding
Initial funding for the EPOCH Collaboration has been
received from the Meat and Livestock Association of
Australia and further funding will continue to be sought
from relevant funding agencies. Each individual trial has
received funding from their own respective funding
bodies, including the National Health and Medical
Research Council (Australia), Health Research Council
(New Zealand) and the Sydney South West Area Health
Service. Funding bodies must provide support on condi-
tion that they will not have any input into the protocol
design, data collection, data analysis or in any decisions
to publish the results of the EPOCH Collaboration or
any of the individual trials.
Summary
We have described the protocol for the EPOCH Colla-
boration which is the first individual patient data pro-
spective meta-analysis of early childhood obesity
prevention trials in the world. It will help to answer a
key public health question: do interventions implemen-
ted in the first year of life prevent obesity, and influence
weight status and a range of lifestyle-relevant beha-
vioural outcomes at 18-24 months of age? We anticipate
that the results will be available for publication in 2013
(see Table 2). The proposed research pushes knowledge
boundaries in terms of the individual trials and the use
of the innovative IPD PMA methodology. The informa-
tion obtained from the EPOCH Collaboration is needed
to justify investment in child health services to provide
universal access to best-practice programs that are the
most effective in reducing the prevalence of childhood
obesity and associated negative short- and long-term
health outcomes.
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